Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Internal Medicine
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Internal Medicine
Patients who want to make you retire, and how to cope
MDedge Internal Medicine
Infective endocarditis isn’t what it used to be
MDedge Internal Medicine
Esketamine gets the green light for depression
MDedge Internal Medicine
Ready for universal hepatitis C testing?
MDedge Internal Medicine
Alcohol-mediated renal denervation appears safe for BP reduction
MDedge Internal Medicine
Autism risk with in utero infections
MDedge Internal Medicine
Aspirin and lower risk of COPD flare-up
MDedge Internal Medicine
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Internal Medicine